Thermo Fisher Scientific (TMO) Enterprise Value (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Enterprise Value for 18 consecutive years, with -$3.2 billion the latest figure, recorded in Q1 2026.

• Enterprise Value for Q1 2026 came in at -$3.2 billion, up 44.17% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.2 billion (up 44.17% YoY), and the FY2025 annual result was -$10.1 billion, down 85.28% from the prior year.
• Enterprise Value was -$3.2 billion for Q1 2026 at Thermo Fisher Scientific, up from -$10.1 billion in the prior quarter.
• Over five years, Enterprise Value peaked at -$1.8 billion in Q3 2022 and troughed at -$10.1 billion in Q4 2025.
• Average Enterprise Value over 5 years is -$5.4 billion, with a median of -$5.8 billion recorded in 2025.
• Year-over-year, Enterprise Value surged 76.72% in 2022 and slumped 188.34% in 2024.
• Over 5 years, Enterprise Value stood at -$8.4 billion in 2022, then grew by 5.3% to -$8.0 billion in 2023, then soared by 31.55% to -$5.4 billion in 2024, then sank by 85.28% to -$10.1 billion in 2025, then jumped by 67.83% to -$3.2 billion in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$3.2 billion in Q1 2026, -$10.1 billion in Q4 2025, and -$3.4 billion in Q3 2025.